VIOL Co (XKRX:335890) Debt-to-Equity : 0.01 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is VIOL Co Debt-to-Equity?

VIOL Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩460 Mil. VIOL Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩339 Mil. VIOL Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₩88,817 Mil. VIOL Co's debt to equity for the quarter that ended in Dec. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for VIOL Co's Debt-to-Equity or its related term are showing as below:

XKRX:335890' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.15
Current: 0.01

During the past 6 years, the highest Debt-to-Equity Ratio of VIOL Co was 0.15. The lowest was 0.01. And the median was 0.03.

XKRX:335890's Debt-to-Equity is ranked better than
99.86% of 692 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XKRX:335890: 0.01

VIOL Co Debt-to-Equity Historical Data

The historical data trend for VIOL Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIOL Co Debt-to-Equity Chart

VIOL Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.15

0.02

0.03

0.01

VIOL Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Competitive Comparison of VIOL Co's Debt-to-Equity

For the Medical Devices subindustry, VIOL Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIOL Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VIOL Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where VIOL Co's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

VIOL Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

VIOL Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(460.452	+	339.01)	/	88816.577
	=	0.01

VIOL Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(460.452	+	339.01)	/	88816.577
	=	0.01

VIOL Co (XKRX:335890) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

VIOL Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of VIOL Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

VIOL Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VIOL Co Ltd (XKRX:335890) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

744 Pangyo-ro, Bundagu-gu, C-808, 809 Bundang Technopark C, Gyeonggi-do, Seoul, KOR, 13510

Website

http://www.viol.co.kr

VIOL Co Ltd is engaged in manufacturing and marketing of medical devices for skincare treatment and recovery. The product portfolio includes SkinStamp, SYLFIRM, SCARLET, O Media - RS, O Media - RI, and O Media - Hmgf H.

VIOL Co Headlines

No Headlines